World News: 13:15 GMT Thursday 17th May 2018. [Veru Inc. via Globe Newswire via SPi World News]
MIAMI May 17 2018 GLOBE NEWSWIRE -- Veru Inc NASDAQ VERU a urology and oncology biopharmaceutical company today announced the publication of data from preclinical studies of VERU-111 a novel oral alpha and beta tubulin inhibitor showi ng pote...
Globe Newswire: 13:15 GMT Thursday 17th May 2018
SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2019. [Admin Only]
Sector Publishing Intelligence Ltd.
Agriculture House, Acland Road, DORCHESTER, Dorset DT1 1EF United Kingdom
Registered in England and Wales number 07519380.